|
MORC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.974840E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.480200E-03 |
| Normal-vs-Stage2 |
2.049600E-01 |
| Normal-vs-Stage3 |
1.006360E-02 |
| Normal-vs-Stage4 |
7.680200E-03 |
| Stage1-vs-Stage2 |
7.346800E-01 |
| Stage1-vs-Stage3 |
8.085000E-01 |
| Stage1-vs-Stage4 |
4.919400E-01 |
| Stage2-vs-Stage3 |
6.235400E-01 |
| Stage2-vs-Stage4 |
3.897600E-01 |
| Stage3-vs-Stage4 |
6.240800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.664400E-03 |
| Normal-vs-AfricanAmerican |
1.493450E-01 |
| Normal-vs-Asian |
8.216100E-04 |
| Caucasian-vs-AfricanAmerican |
4.232200E-01 |
| Caucasian-vs-Asian |
1.492970E-01 |
| AfricanAmerican-vs-Asian |
7.552000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.099900E-02 |
| Normal-vs-Female |
1.640030E-04 |
| Male-vs-Female |
1.449410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.889500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.036200E-04 |
| Normal-vs-Age(61-80Yrs) |
8.718200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.920400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.731600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.828000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.336000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.614400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.602000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.794600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.054600E-01 |
| Classical-VS-Follicular |
3.59730001342484E-09 |
| Classical-VS-Other |
7.372800E-01 |
| Classical-VS-Normal |
2.23669999999121E-06 |
| Tall-VS-Follicular |
4.716600E-03 |
| Tall-VS-Other |
5.326600E-01 |
| Tall-VS-Normal |
1.787890E-02 |
| Follicular-VS-Other |
3.165600E-01 |
| Follicular-VS-Normal |
1.499190E-01 |
| Other-VS-Normal |
4.852600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.978500E-02 |
| Normal-vs-N1 |
1.452960E-01 |
| N0-vs-N1 |
8.214200E-01 |
|
|
